576. Alprazolam for symptom relief: addressing the more troublesome features of anxiety disorders
S Shirol, S Awasthi, A Fagiolini, K Subramaniam, P Purushottamahanti · 2026
Read 576. Alprazolam for symptom relief: addressing the more troublesome features of anxiety disorders by S Shirol, S Awasthi, A Fagiolini, K Subramaniam, P Purushottamahanti (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13556373.txt.
Description
Shirol and four co-authors pool trial data on alprazolam, a fast-acting anxiety drug, focusing on the symptom cluster patients find most troublesome. Anxiety disorders are the world's most common mental disorders, and the generalized form disables through three channels: muscle and body tension, an overactive automatic nervous system, and racing, watchful thoughts. The team mapped those features onto items of a standard rating scale. Four short-term trials in severely anxious adults fed the combined analysis.
Across the trials the drug eased every mapped cluster, with the largest average gain on the automatic symptoms. The authors credit the drug's boost to the brain's main calming receptor system. They caution that risks of dependence, tolerance, and sedation call for the lowest effective dose. Treatment should stay short, with a planned taper at the end.
Catalog record
| CREATOR | S Shirol, S Awasthi, A Fagiolini, K Subramaniam, P Purushottamahanti |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |